Mason Michael's Form 4 filing
Karyopharm Therapeutics Inc. (KPTI) · filed Feb 29, 2024
- Accession no.
- 0000950170-24-023292
- Filed
- Feb 29, 2024
- Trade date
- Feb 27-28, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $3.36K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mason MichaelCIK 0001514291 | Officer (EVP, CFO & Treasurer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 27, 2024 | Common Stock | SSaleDisposed | −2,545 | $1.32 | −$3,359.4 | 244,400 | Direct | |
| Feb 28, 2024 | Common Stock | AGrant or awardAcquired | +188,205 | $0.00 | $0 | 432,605 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.